Molecular Templates, Inc. (NASDAQ:MTEM) Expected to Post Quarterly Sales of $6.38 Million

Brokerages expect that Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) will announce $6.38 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Molecular Templates’ earnings. The lowest sales estimate is $4.00 million and the highest is $8.75 million. Molecular Templates posted sales of $15.13 million during the […]

Related Keywords

United States ,America ,Stifel Nicolaus ,Geode Capital Management ,Zacks Investment Research ,Blackrock Inc ,Bellevue Group ,Nasdaq ,Frazier Life Sciences Management ,Molecular Templates Inc ,Barclays ,Molecular Templates ,Get Rating ,Molecular Template ,Investment Research ,Capital Partners ,Capital Management ,Nasdaq Mtem ,Temtem ,Medical ,88580720 ,Ratings ,Consensus ,